Your browser doesn't support javascript.
loading
Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United States.
Jorge, Soledad; Goff, Barbara A; Gray, Heidi J; Enquobahrie, Daniel A; Doll, Kemi M.
Affiliation
  • Jorge S; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.
  • Goff BA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.
  • Gray HJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.
  • Enquobahrie DA; Department of Epidemiology, University of Washington, Seattle, WA.
  • Doll KM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.
JCO Oncol Pract ; 17(11): e1698-e1710, 2021 11.
Article in En | MEDLINE | ID: mdl-33844592
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: JCO Oncol Pract Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: JCO Oncol Pract Year: 2021 Document type: Article Country of publication: